| Identification | Back Directory | [Name]
N-(4-Mesitylthiazol-2-yl)benzaMide | [CAS]
1001753-24-7 | [Synonyms]
INH6
INH-6; INH6
1001753-24-7
N-(4-Mesitylthiazol-2-yl)benzaMide
N-(4-Mesitylthiazol-2-yl)benzaMide USP/EP/BP
N-[4-(2,4,6-trimethylphenyl)thiazol-2-yl]benzamide
N-[4-(2,4,6-trimethylphenyl)-2-thiazolyl]-benzamide | [Molecular Formula]
C19H18N2OS | [MDL Number]
MFCD04722622 | [MOL File]
1001753-24-7.mol | [Molecular Weight]
322.424 |
| Hazard Information | Back Directory | [Uses]
INH6 is a Hec1 inhibitor that targets the Hec1/Nek2 pathway and causes chromosome mis-alignment as well as cell death. | [Biological Activity]
inh6 is a potent inhibitor of hec1/nek2 [1].hec1 is an oncogene that involved in spindle checkpoint signaling and is overexpressed in many human cancers. nek2 is a serine/threonine-protein kinase that phosphorylates hec1, which is critical for its mitotic function and cell survival [1].inh6 is a potent hec1/nek2 inhibitor. inh6 inhibited hec1/nek2 function through protein degradation that led to chromosome mis-segregation and cell death. in mda-mb468 and mda-mb231 human breast cancer cell lines, hela human cervical cancer line and k562 human erythromyeloblastoid leukemia cell line, inh6 exhibited significantly anti-proliferation activities with ic50 values of 2.1, 1.7, 2.4 and 2.5 μm, respectively. in hela cell extract, inh6-conjugated matrix selectively co-precipitated with cellular hec1, which suggested that inh6 bound to cellular hec1. in hela cells, inh6 (6.25 μm) reduced nek2 by 50% at 8-11 h. in addition, inh6 slightly reduced hec1 over time. also, inh6 increased mitotic population with multipolar spindle configurations. in hela cells expressing the chromosome marker protein h2b-gfp, inh6 increased chromosome misalignment. in hela cells, inh6 exhibited progressive morphological changes of dying cells and induced apoptosis by 20% [1]. | [target]
Hec1/Nek2 complex | [storage]
Desiccate at -20°C | [References]
[1]. qiu xl, li g, wu g, et al. synthesis and biological evaluation of a series of novel inhibitor of nek2/hec1 analogues. j med chem, 2009, 52(6): 1757-1767. |
|
|